AMBEEPHA Stock Overview
Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Ambee Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳719.90 |
| 52 Week High | ৳1,302.30 |
| 52 Week Low | ৳510.00 |
| Beta | -0.31 |
| 1 Month Change | -6.47% |
| 3 Month Change | -11.05% |
| 1 Year Change | 29.64% |
| 3 Year Change | 76.58% |
| 5 Year Change | 13.93% |
| Change since IPO | 4,446.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMBEEPHA | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | 0.2% | -3.0% | -3.1% |
| 1Y | 29.6% | -16.7% | -19.4% |
Return vs Industry: AMBEEPHA exceeded the BD Pharmaceuticals industry which returned -15% over the past year.
Return vs Market: AMBEEPHA exceeded the BD Market which returned -18.2% over the past year.
Price Volatility
| AMBEEPHA volatility | |
|---|---|
| AMBEEPHA Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in BD Market | 8.6% |
| 10% least volatile stocks in BD Market | 3.3% |
Stable Share Price: AMBEEPHA has not had significant price volatility in the past 3 months.
Volatility Over Time: AMBEEPHA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1976 | 477 | Naureen Aziz Bhai | www.ambeepharma.com |
Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal and anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid drugs, diuretic agents, non-steroidal anti-inflammatory, steroidal anti-inflammatory drugs, haematinic, and vitamins and minerals. It also provides its products in form of tablets, capsules, liquids, tubes, and injections.
Ambee Pharmaceuticals PLC Fundamentals Summary
| AMBEEPHA fundamental statistics | |
|---|---|
| Market cap | ৳1.61b |
| Earnings (TTM) | ৳10.53m |
| Revenue (TTM) | ৳209.27m |
164.1x
P/E Ratio8.3x
P/S RatioIs AMBEEPHA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBEEPHA income statement (TTM) | |
|---|---|
| Revenue | ৳209.27m |
| Cost of Revenue | ৳97.24m |
| Gross Profit | ৳112.04m |
| Other Expenses | ৳101.51m |
| Earnings | ৳10.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 28, 2024
| Earnings per share (EPS) | 4.39 |
| Gross Margin | 53.54% |
| Net Profit Margin | 5.03% |
| Debt/Equity Ratio | 1,874.0% |
How did AMBEEPHA perform over the long term?
See historical performance and comparison